Showing results (321-330 of 342) with videos related to

Sort By:
Pageof 35
Journal of Insect Science (Online)|April 28, 2021
Technological Advances to Address Current Issues in Entomology: 2020 Student DebatesLina Bernaola, Molly Darlington, Kadie Britt, et al.
Blood|December 11, 2012
High frequency of GATA2 mutations in patients with mild chronic neutropenia evolving to MonoMac syndrome, myelodysplasia, and acute myeloid leukemiaMarlène Pasquet, Christine Bellanné-Chantelot, Suzanne Tavitian, et al.
The Journal of Biological Chemistry|January 29, 2014
Mechanistic strategies for catalysis adopted by evolutionary distinct family 43 arabinanasesCamila R Santos, Carla C Polo, Maria C M F Costa, et al.
Bioorganic & Medicinal Chemistry Letters|September 26, 2012
Structure-guided design, synthesis and biological evaluation of novel DNA ligase inhibitors with in vitro and in vivo anti-staphylococcal activityJean-Philippe Surivet, Roland Lange, Christian Hubschwerlen, et al.
Haematologica|February 2, 2023
Somatic genetic alterations predict hematological progression in GATA2 deficiencyLaetitia Largeaud, Matthew Collin, Nils Monselet, et al.
Cell Metabolism|January 14, 2022
Atlas of exercise metabolism reveals time-dependent signatures of metabolic homeostasisShogo Sato, Kenneth A Dyar, Jonas T Treebak, et al.
Blood|October 20, 2020
del(17p) without TP53 mutation confers a poor prognosis in intensively treated newly diagnosed patients with multiple myelomaJill Corre, Aurore Perrot, Denis Caillot, et al.
Journal of Toxicology and Environmental Health. Part A|December 15, 2024
Cocoa (Theobroma cacao L.) photobiological effect on human fibroblast cells (HFF-1) exposed to ultraviolet B (UVB) radiationJosiéle da Silva Prade, Camila Medianeira da Silva D'Ávila, Thayline Correia da Silva, et al.
Leukemia|October 4, 2016
NUP98 is rearranged in 3.8% of pediatric AML forming a clinical and molecular homogenous group with a poor prognosisS Struski, S Lagarde, P Bories, et al.
The Lancet. Rheumatology|June 26, 2025
Disease-associated brain activation predicts clinical response to TNF inhibition in rheumatoid arthritis (PreCePra): a randomised, multicentre, double-blind, placebo-controlled phase 3 studyAndreas Hess, Koray Tascilar, Hanna M Schenker, et al.
Pageof 35